The association between adiposity and pulmonary vascular resistance may be attributed to the adverse effects of pro-inflammatory adipokines (39), co-existing obstructive sleep apnea (40, 41), or decreased adiponectin (39, 42). The gene discussed is ADIPOQ; the disease is obstructive sleep apnea syndrome.